🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Hexal AG — Licensed Medicines

18 medicines held by Hexal AG on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 18 products held by Hexal AG
MedicineActive substanceLicence holderStatus
Epoetin alfa HEXAL 1 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/411/1-2
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 10 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/411/15-16
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 2 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/411/3-4
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 20 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/411/21-22
Epoetin alfa Hexal AG
Epoetin alfa HEXAL 3 000 IU/0.3 mL solution for injection in a pre-filled syringe
EU/1/07/411/5-6
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 30 000 IU/0.75 mL solution for injection in a pre-filled syringe
EU/1/07/411/23-24
Epoetin alfa Hexal AG
Epoetin alfa HEXAL 4 000 IU/0.4 mL solution for injection in a pre-filled syringe
EU/1/07/411/7-8
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 40 000 IU/1 mL solution for injection in a pre-filled syringe
EU/1/07/411/25-26
Epoetin alfa Hexal AG
Epoetin alfa HEXAL 5 000 IU/0.5 mL solution for injection in a pre-filled syringe
EU/1/07/411/9-10
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 6 000 IU/0.6 mL solution for injection in a pre-filled syringe
EU/1/07/411/11-12
Recombinant human erythropoietin alfa Hexal AG
Epoetin alfa HEXAL 8 000 IU/0.8 mL solution for injection in a pre-filled syringe
EU/1/07/411/13-14
Recombinant human erythropoietin alfa Hexal AG
Filgrastim Hexal 30 MU (60 MU/ml) Solution for injection or infusion
EU/1/08/496/1-4
Ep2006 (recombinant human granulocyte-colony stimulating factor) Hexal AG
Filgrastim Hexal 48 MU (96 MU/ml) Solution for injection or infusion
EU/1/08/496/5-8
Ep2006 (recombinant human granulocyte-colony stimulating factor) Hexal AG
Rivastigmine HEXAL 1.5 mg hard capsules
EU/1/09/589/1-4
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 2 mg/ml oral solution
EU/1/09/589/017-018
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 3 mg hard capsules
EU/1/09/589/5-8
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 4.5 mg hard capsules
EU/1/09/589/9-12
Rivastigmine hydrogen tartrate Hexal AG
Rivastigmine HEXAL 6 mg hard capsules
EU/1/09/589/13-16
Rivastigmine hydrogen tartrate Hexal AG
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.